Viridian Therapeutics, Inc. · NASDAQ:VRDN

State Street Corp reported a 5.50% stake in Viridian Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 7, 2026

State Street Corp reported a 5.50% stake in Viridian Therapeutics, Inc., 6,124,976 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).

Stake
5.50%
Shares
6,124,976
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
STATE STREET CORPORATION5.50%6,124,976

Source

View original at SEC

Related